DUBLIN--(BUSINESS WIRE)--The "Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical & Biotech Companies, CROs, BPOs), And Segment Forecasts, 2018 - 2024" report has been added to ResearchAndMarkets.com's offering.
Manufacturers are now striving to identify various ways of cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in short as well as long terms. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes.
PV service providers, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These firms are also incorporating integrated technologies such as electronic data capture and hosting of PV warehousing for aggregating cross industry data for benefit risk evaluation. Furthermore, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period.
Key Topics Covered:
Chapter 1 Research Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends& Scope
Chapter 5 Functionality Estimates & Trend Analysis
Chapter 6 Delivery Mode Estimates & Trend Analysis
Chapter 7 End-use Estimates & Trend Analysis
Chapter 8 Regional Estimates & Trend Analysis, by Functionality, Delivery Mode, and End-use
Chapter 9 Competitive Landscape
- AB cube
- Max Application
- Ennov Solutions, Inc.
- ArisGlobal
- EXTEDO GmbH
- Online Business Applications, Inc.
- Oracle Corporation
- Sparta Systems, Inc.
- United BioSource Corporation
- Relsys
